Risk of Venous Thromboembolism after New Onset Heart Failure

[1]  Francesca N. Delling,et al.  Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association , 2019, Circulation.

[2]  J. Cleland,et al.  Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease , 2018, The New England journal of medicine.

[3]  M. Limacher,et al.  Venous thromboembolism incidence, recurrence, and mortality based on Women's Health Initiative data and Medicare claims. , 2017, Thrombosis research.

[4]  A. Mebazaa,et al.  Predicting the Risk of Venous Thromboembolism in Patients Hospitalized With Heart Failure , 2014, Circulation.

[5]  Richard B Devereux,et al.  Risk of a thrombotic event after the 6-week postpartum period. , 2014, The New England journal of medicine.

[6]  Elie A Akl,et al.  Prevention of VTE in Nonsurgical Patients Antithrombotic Therapy and Prevention of Thrombosis , 9 th ed : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines , 2013 .

[7]  P. Shekelle,et al.  Venous Thromboembolism Prophylaxis in Hospitalized Patients: A Clinical Practice Guideline From the American College of Physicians , 2011, Annals of Internal Medicine.

[8]  R. Goldberg,et al.  Venous thromboembolism in heart failure: preventable deaths during and after hospitalization. , 2011, The American journal of medicine.

[9]  P. Prandoni,et al.  A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score , 2010, Journal of thrombosis and haemostasis : JTH.

[10]  Banafsheh Sadeghi,et al.  Evaluation of the predictive value of ICD-9-CM coded administrative data for venous thromboembolism in the United States. , 2010, Thrombosis research.

[11]  P. Stein,et al.  Risk of venous thromboembolism in patients hospitalized with heart failure. , 2006, The American journal of cardiology.

[12]  A. Turpie,et al.  Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study. , 2004, Archives of internal medicine.

[13]  L. Melton,et al.  Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. , 2002, Archives of internal medicine.

[14]  M. Samama,et al.  An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. , 2000, Archives of internal medicine.

[15]  D. Levy,et al.  Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. , 1999, Journal of the American College of Cardiology.

[16]  S. Leeder,et al.  A population based study , 1993, The Medical journal of Australia.

[17]  D. Levy,et al.  Survival After the Onset of Congestive Heart Failure in Framingham Heart Study Subjects , 1993, Circulation.

[18]  G. Lip,et al.  Heart failure and risk of venous thromboembolism: a systematic review and meta-analysis. , 2016, The Lancet. Haematology.

[19]  M. Biddle,et al.  A report from the American Heart Association Council on Cardiovascular and Stroke Nursing. , 2015, The Journal of cardiovascular nursing.

[20]  E. Akl,et al.  Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[21]  Zach Jenkins.  The Padua Prediction Score , 2013 .

[22]  Salim Yusuf,et al.  Predictors of mortality and morbidity in patients with chronic heart failure. , 2006, European heart journal.